Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00183794
Status:
COMPLETED
Last Update Posted:
2014-05-22
First Post:
2005-09-09
Brief Title:
Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma
Sponsor:
University of Southern California
Organization:
University of Southern California
Organization Data
Organization:
University of Southern California
Class:
OTHER
Study ID:
5GYN-02-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Southern California
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Aventis Pharmaceuticals | INDUSTRY |
| Eli Lilly and Company | INDUSTRY |